Toremifene versus tamoxifen for advanced breast cancer-Reference-Cited by-同舟云学术

Toremifene versus tamoxifen for advanced breast cancer

Published:2012-07-11 Issue:2 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mao Chen¹,Yang Zu-Yao¹,He Ben-Fu²,Liu Shan³,Zhou Jun-Hua⁴,Luo Rong-Cheng²,Chen Qing⁴,Tang Jin-Ling¹

Affiliation:

1. Division of Epidemiology, The Jockey Club School of Public Health and Primary Care; The Chinese University of Hong Kong; Hong Kong SAR China

2. Department of Oncology; Nanfang Hospital, Southern Medical University; Guangzhou China

3. Department of Clinical Evaluation Center; The First Affiliated Hospital of Zhejiang Chinese Medical University; Hangzhou China

4. Department of Epidemiology; School of Public Health and Tropical Medicine, Southern Medical University; Guangzhou China

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008926.pub2/fullpdf

Reference72 articles.

1. A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer;Gershanovich;Breast Cancer Research and Treatment,1997

2. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer;Hayes;Journal of Clinical Oncology,1995

3. Pyrhonen S Ellmen J Vuorinen J Gershanovich M Tominaga T Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer Breast Cancer Research and Treatment 1999 56 133 43

4. Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer;Milla-Santos;Breast Cancer Research and Treatment,2001

5. Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen;Nomura;Japanese Journal of Cancer and Chemotherapy (Gan to Kagaku Ryoho),1993

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023

2. Mechanisms of endocrine therapy resistance in breast cancer;Molecular and Cellular Endocrinology;2021-07

3. Chinese breast cancer patients with CYP2D6 *10 mutant genotypes have a better prognosis with toremifene than with tamoxifen;Asia-Pacific Journal of Clinical Oncology;2021-06-30

4. Tamoxifen and aromatase inhibitors for relapse of tubo-ovarian high-grade serous cancer;Cochrane Database of Systematic Reviews;2021-04-30

5. Repurposing anticancer drugs for the management of COVID-19;European Journal of Cancer;2020-12